|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
20,430,000 |
Market
Cap: |
1.37(B) |
Last
Volume: |
2,387,520 |
Avg
Vol: |
2,380,888 |
52
Week Range: |
$38.04 - $69.69 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile ANI Pharmaceuticals is a bio-pharmaceutical company focused on developing, manufacturing, and marketing branded and generic prescription pharmaceuticals. Co.'s products include: Candesartan Hydrochlorothiazide, Fenofibrate, Fluvoxamine, Hydrocortisone Enema, Lithium Carbonate ER, Mesalamine, Propranolol ER, Terbutaline, and Vancomycin.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
217,191 |
449,536 |
1,290,012 |
1,508,078 |
Total Sell Value |
$14,172,429 |
$28,322,617 |
$76,321,972 |
$84,695,041 |
Total People Sold |
8 |
10 |
12 |
12 |
Total Sell Transactions |
22 |
43 |
90 |
93 |
End Date |
2024-03-10 |
2023-12-08 |
2023-06-09 |
2022-06-09 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Brown Robert E. Jr |
Director |
|
2014-03-14 |
4 |
S |
$33.85 |
$1,008,091 |
D/D |
(29,659) |
2,702,362 |
|
- |
|
Raynor Daniel |
Director |
|
2014-03-14 |
4 |
S |
$33.85 |
$417,946 |
I/I |
(12,347) |
524,182 |
|
- |
|
Brown Robert E. Jr |
Director |
|
2014-03-13 |
4/A |
S |
$31.05 |
$1,660,368 |
D/D |
(52,404) |
2,732,021 |
|
- |
|
Brown Robert E. Jr |
Chairman |
|
2014-03-13 |
4 |
S |
$31.69 |
$1,660,683 |
D/D |
(52,404) |
16,830,746 |
|
- |
|
Raynor Daniel |
Director |
|
2014-03-12 |
4/A |
S |
$33.85 |
$715,556 |
I/I |
(21,111) |
536,529 |
|
- |
|
Brown Robert E. Jr |
Director |
|
2014-03-12 |
4/A |
S |
$33.61 |
$1,188,884 |
D/D |
(35,319) |
2,784,425 |
|
- |
|
Brown Robert E. Jr |
Chairman |
|
2014-03-12 |
4 |
S |
$33.66 |
$1,188,838 |
D/D |
(35,319) |
16,883,150 |
|
- |
|
Raynor Daniel |
Director |
|
2014-03-12 |
4 |
S |
$33.89 |
$715,452 |
I/I |
(21,111) |
3,324,738 |
|
- |
|
Arnold Charlotte C. |
Chief Financial Officer |
|
2014-03-06 |
4 |
D |
$36.64 |
$73,287 |
D/D |
(2,000) |
60,404 |
|
- |
|
Przybyl Arthur |
President and CEO |
|
2014-03-05 |
4 |
D |
$36.57 |
$206,298 |
D/D |
(5,641) |
175,368 |
|
- |
|
Przybyl Arthur |
President and CEO |
|
2014-03-05 |
4 |
A |
$0.00 |
$0 |
D/D |
12,139 |
181,009 |
|
- |
|
Arnold Charlotte C. |
Chief Financial Officer |
|
2014-03-05 |
4 |
D |
$36.43 |
$49,436 |
D/D |
(1,357) |
62,404 |
|
- |
|
Arnold Charlotte C. |
Chief Financial Officer |
|
2014-03-05 |
4 |
A |
$0.00 |
$0 |
D/D |
3,675 |
63,761 |
|
- |
|
Arnold Charlotte C. |
Chief Financial Officer |
|
2014-02-25 |
4 |
D |
$32.77 |
$44,693 |
D/D |
(1,364) |
60,086 |
|
- |
|
Arnold Charlotte C. |
Chief Financial Officer |
|
2014-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
3,675 |
61,450 |
|
- |
|
Przybyl Arthur |
President and CEO |
|
2014-02-25 |
4 |
D |
$32.86 |
$185,475 |
D/D |
(5,644) |
168,870 |
|
- |
|
Przybyl Arthur |
President and CEO |
|
2014-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
12,139 |
174,514 |
|
- |
|
Przybyl Arthur |
President and CEO |
|
2014-02-12 |
4 |
D |
$21.00 |
$118,521 |
D/D |
(5,644) |
162,375 |
|
- |
|
Przybyl Arthur |
President and CEO |
|
2014-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
12,139 |
168,019 |
|
- |
|
Arnold Charlotte C. |
Chief Financial Officer |
|
2014-02-12 |
4 |
D |
$21.00 |
$28,641 |
D/D |
(1,364) |
57,775 |
|
- |
|
Arnold Charlotte C. |
Chief Financial Officer |
|
2014-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
3,675 |
59,139 |
|
- |
|
Arnold Charlotte C. |
Chief Financial Officer |
|
2014-02-05 |
4 |
D |
$19.83 |
$27,043 |
D/D |
(1,364) |
55,464 |
|
- |
|
Arnold Charlotte C. |
Chief Financial Officer |
|
2014-02-05 |
4 |
A |
$0.00 |
$0 |
D/D |
3,675 |
56,828 |
|
- |
|
Przybyl Arthur |
President and CEO |
|
2014-02-05 |
4 |
D |
$19.79 |
$111,701 |
D/D |
(5,644) |
155,880 |
|
- |
|
Przybyl Arthur |
President and CEO |
|
2014-02-05 |
4 |
A |
$0.00 |
$0 |
D/D |
12,139 |
161,524 |
|
- |
|
722 Records found
|
|
Page 18 of 29 |
|
|